| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/01/2013 | US20130195910 Vaccine delivery method |
| 08/01/2013 | US20130195839 Polymer-Based Compositions and Conjugates of Antimicrobial Agents |
| 08/01/2013 | US20130195831 Silk-based drug delivery system |
| 08/01/2013 | US20130195791 Conjugates comprising an n-oxime bond and associated methods |
| 08/01/2013 | US20130195771 Gantrez Hydrogel With Dry Tack |
| 08/01/2013 | US20130195769 Oleaginous pharmaceutical and cosmetic foam |
| 08/01/2013 | US20130195757 Sparc binding aptamers and uses thereof |
| 08/01/2013 | US20130195754 IL-l BINDING PROTEINS |
| 08/01/2013 | US20130195752 Functionalized nanoparticles and methods of use thereof |
| 08/01/2013 | US20130195751 Self-assembed conjugate and use thereof |
| 08/01/2013 | CA2861947A1 A drug delivery system |
| 08/01/2013 | CA2861335A1 Targeting interferon-lambda with antibodies potently enhances anti-tumor and anti-viral activities |
| 08/01/2013 | CA2857127A1 Integrin antagonist conjugates for targeted delivery to cells expressing lfa-1 |
| 08/01/2013 | CA2856619A1 Integrin antagonist conjugates for targeted delivery to cells expressing alpha-v-beta-3 |
| 08/01/2013 | CA2854254A1 Integrin antagonist conjugates for targeted delivery to cells expressing vla-4 |
| 08/01/2013 | CA2854251A1 Chitosan covalently linked with small molecule integrin antagonist for targeted delivery |
| 07/31/2013 | EP2620423A1 Improved methods for preparing squalene |
| 07/31/2013 | EP2620163A1 Oligomer-opioid agonist conjugates |
| 07/31/2013 | EP2620162A1 Enzyme-polymer conjugate for endotoxin detoxification |
| 07/31/2013 | EP2620161A1 Diblock copolymers and polynucleotide complexes thereof for delivery into cells |
| 07/31/2013 | EP2620153A1 5 alpha-androstane (alkyl)-3 beta,5,6 beta-triol injection and preparation method therefor |
| 07/31/2013 | EP2620152A1 Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same |
| 07/31/2013 | EP2620138A2 Foam-type external skin preparation |
| 07/31/2013 | EP2619238A1 Novel block copolymer and micelle compositions and methods of use thereof |
| 07/31/2013 | EP2619210A1 Process for chelating copper ions using cb-te2a bifunctional chelate |
| 07/31/2013 | EP2619175A1 Enhanced transbuccal drug delivery system and compositions |
| 07/31/2013 | EP2618859A1 Composition for active principles delivery by implant devices |
| 07/31/2013 | EP2618846A1 Aptamer conjugates for targeting of therapeutic and/or diagnostic nanocarriers |
| 07/31/2013 | EP2618845A1 Tunable, biodegradable linker molecules for transient conjugation of components in drug delivery systems, and drug delivery systems prepared therewith |
| 07/31/2013 | EP2618844A2 Oral composition and method of forming and using same |
| 07/31/2013 | EP2618821A2 Nanostructured gels capable of controlled release of encapsulated agents |
| 07/31/2013 | EP2618817A2 Liposome targeting compounds and related uses |
| 07/31/2013 | EP2618814A1 Caspofungin composition |
| 07/31/2013 | CN203089942U Tiamulin long-acting particle pill |
| 07/31/2013 | CN203089533U Operation system using laser heat for treating fundus diseases |
| 07/31/2013 | CN1927189B Percutaneous absorption-type pharmaceutical preparations |
| 07/31/2013 | CN103228725A Novel polymeric thickening agent free of acrylamide fragments, method for the preparation thereof, and composition containing same |
| 07/31/2013 | CN103228687A Novel cationic thickeners, free of oil and surfactants, method for preparing same, and composition containing same |
| 07/31/2013 | CN103228676A Hydroxyalkyl cellulose |
| 07/31/2013 | CN103228296A Bendamustine anionic-atioinic cyclopolysaccharide compositions |
| 07/31/2013 | CN103228283A Oil-in-water emulsion composition containing difluprednate and tobramycin |
| 07/31/2013 | CN103228280A Injectable liquid composition containing revaprazan or revaprazan salt |
| 07/31/2013 | CN103228279A Injectable liquid composition or injectable drypowder containing revaprazan or its salt |
| 07/31/2013 | CN103228277A Preparation for improving solubility of poorly soluble drug |
| 07/31/2013 | CN103228265A Liquid formulations of long acting interferon alpha conjugate |
| 07/31/2013 | CN103228258A Novel cationic thickeners usable over a wide pH range, method for the preparation thereof, and composition containing same |
| 07/31/2013 | CN103228257A Novel electrolyte-resistant cationic thickeners usable over a wide pH range, method for preparing same, and composition containing same |
| 07/31/2013 | CN103224957A Method for producing red blood cell drug containing L-ASPase II by in vitro induction |
| 07/31/2013 | CN103224702A Reductive and sensitive type polyaminoacid nano-hydrogel and preparation method thereof |
| 07/31/2013 | CN103224624A Triblock copolymer polyethyleneimine (PEI)-polyethylene glycol (PEG)-PEI |
| 07/31/2013 | CN103224610A Sustained-and-controlled-release acid-sensitive cationic polymer gene vector with branched structure, and preparation method and application thereof |
| 07/31/2013 | CN103224575A Acrylamide chitin and preparation method thereof |
| 07/31/2013 | CN103224557A Development of long-acting fibroblast growth factor-23 antagonist |
| 07/31/2013 | CN103224514A Production technology of high-purity egg yolk lecithin |
| 07/31/2013 | CN103223189A Bone cement in paste form |
| 07/31/2013 | CN103223188A Paste-like bone cement |
| 07/31/2013 | CN103223187A Sanitary napkins with hydrophobic lotions |
| 07/31/2013 | CN103223174A Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| 07/31/2013 | CN103223173A Capsule polyurethane drug controlled release body with temperature control switch, and preparation method thereof |
| 07/31/2013 | CN103223171A Porphyrin and uptransition rare earth nanocomposite, preparation method and application thereof |
| 07/31/2013 | CN103223170A Stilbene and uptransition rare earth nanocomposite, preparation method and application thereof |
| 07/31/2013 | CN103223169A Nanocomposite of curcumin and upconversion rare earth, preparation method and application thereof |
| 07/31/2013 | CN103223168A Quinine and uptransition rare earth nanocomposite, preparation method and application thereof |
| 07/31/2013 | CN103223160A Cation complexes of insulin compund conjugates, formulation and uses thereof |
| 07/31/2013 | CN103223159A Application of enteric maramins androsaceus glycoprotein microspheres comprising absorption enhancer in preparing pain-relieving and anti-inflammatory medicines |
| 07/31/2013 | CN103222985A High-stability compound chlorhexidine iodohydrin solution and preparation method thereof |
| 07/31/2013 | CN103222977A Granisetron and dexamethasone compound percutaneous controlled release patch and preparation method thereof |
| 07/31/2013 | CN103222976A Praziquantel-containing drug composition |
| 07/31/2013 | CN103222968A Tablet containing flunixin meglumine and preparation method |
| 07/31/2013 | CN103222965A Imatinib mesylate tablet and preparation method thereof |
| 07/31/2013 | CN103222964A Orlistat oral preparation and preparation method thereof |
| 07/31/2013 | CN103222963A 生长抑素冻干粉针剂 Somatostatin freeze-dried powder |
| 07/31/2013 | CN103222961A Injection Cu(DDC)2 protein nano-particle preparation used for treating tumor, and preparation method thereof |
| 07/31/2013 | CN103222960A Oral enalapril maleate timed-release pellet and preparation method thereof |
| 07/31/2013 | CN103222957A Strychnine-beta-cyclodextrin polymer liposome, preparation method and applications thereof |
| 07/31/2013 | CN103222956A Strychnine-hydroxypropyl-beta-cyclodextrin liposome, preparation method and applications thereof |
| 07/31/2013 | CN103222955A Stable solution containing epinastine or hydrochloride of epinastine |
| 07/31/2013 | CN103222954A Solution agent containing loperamide or hydrochloride thereof and preparation method of solution agent |
| 07/31/2013 | CN103222953A Fasudil hydrochloride injection composition and its preparation method |
| 07/31/2013 | CN103222952A Stable solution preparation comprising carteolol or hydrochloride thereof |
| 07/31/2013 | CN103222951A Pharmaceutical composition having relatively low ionic strength |
| 07/31/2013 | CN103222950A Modified amylase-based nanometer helical oil phase-triggered quick-release material and preparation method thereof |
| 07/31/2013 | CN103222931A Compositions |
| 07/31/2013 | CN103222476A Iodic acid solution for aquaculture and preparation method thereof |
| 07/31/2013 | CN102871971B Freeze-dried powder injection of vitamin B6 and preparation method thereof |
| 07/31/2013 | CN102824318B Doxofylline pharmaceutical composition for injection |
| 07/31/2013 | CN102743379B Composition containing eighteen amino acids and preparation method thereof |
| 07/31/2013 | CN102727450B Preparation method of Schisandrin C freeze-dried powder injection |
| 07/31/2013 | CN102716125B Vinpocetine composition and preparation method thereof |
| 07/31/2013 | CN102703489B Construction method for prokaryotic secretory expression vector of protein transduction domain-Apoptin (PTD-Apoptin) fusion protein and application of prokaryotic secretory expression vector |
| 07/31/2013 | CN102697719B Oily drug composition containing vitamin K1 |
| 07/31/2013 | CN102688191B Medicine composition containing vitamin K1 and oil |
| 07/31/2013 | CN102670534B Levamlodipine besylate tablets |
| 07/31/2013 | CN102652833B Gastric targeted drug carrier and preparation method thereof |
| 07/31/2013 | CN102614265B Swelling-diminishing and pain-relieving self-emulsifying ointment |
| 07/31/2013 | CN102558360B Trypsin inhibitor and preparation method and application thereof |
| 07/31/2013 | CN102552317B Iodine glycerol nipple infusion and preparation method thereof |
| 07/31/2013 | CN102552222B Magnesium sulfate wet application |
| 07/31/2013 | CN102451163B Polyporus polysaccharide dispersible tablets, and preparation method thereof |
| 07/31/2013 | CN102406785B Guyuling tablet pharmaceutical composition and preparation method thereof |